Dimethylformamide → 4-[(S)-2-tert-Butoxycarbonylamino-5-(tert-butyl-diphenyl-silanyloxy)-pentanoyl]-piperazine-1-carboxylic acid butyl ester
반응식
[C:1]([O:5][C:6]([NH:8][C@@H:9]([CH2:13][CH2:14][CH2:15][O:16][Si:17]([C:30]([CH3:33])([CH3:32])[CH3:31])([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1)C(O)=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(N1CCOCC1)C.[CH2:42]([O:46]N1CCNCC1=C=O)[CH2:43][CH2:44][CH3:45].[B-](F)(F)(F)F.CCOC(C(C#N)=N[O:67][C:68]([N:72]([CH3:74])[CH3:73])=[N+](C)C)=O.[CH3:77][N:78]([CH:80]=[O:81])[CH3:79]>C(OCC)(=O)C>[CH2:42]([O:46][C:80]([N:78]1[CH2:79][CH2:73][N:72]([C:68](=[O:67])[C@@H:9]([NH:8][C:6]([O:5][C:1]([CH3:3])([CH3:4])[CH3:2])=[O:7])[CH2:13][CH2:14][CH2:15][O:16][Si:17]([C:30]([CH3:31])([CH3:33])[CH3:32])([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][CH:23]=2)[CH2:74][CH2:77]1)=[O:81])[CH2:43][CH2:44][CH3:45]참가 물질
7
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of 1.6 g (S)-2-tert-Butoxycarbonylamino-5-(tert-butyl-diphenyl-silanyloxy)-pentanoic acid in 8 ml DMF were added 1.7 ml N-ethylmorpholine, 1.0 g 1-butoxy-carbonylpiperazine hydrotrifluoroacetate and 1.1 g TOTU. The solution was stirred for 12 h before being diluted with ethyl acetate and extracted subsequently with aqueous LiCl (4%), 0.1 M HCl and saturated aqueous NaHCO3. The crude product obtained after evaporation of the solvent was used without further purification. Yield: 1.8 g.
후처리
- extractionextracted subsequently with aqueous LiCl (4%), 0.1 M HCl and saturated aqueous NaHCO3
출처 및 근거
- ORD 기록
- ord-00fa13226e384e0288545a43d46153a9
- 출처 데이터셋
- uspto-grants-2013_04
- 특허 번호
- US08426420B2
반응 노트
불러오는 중…